Beneficial effect of a polyphenol-rich diet on cardiovascular risk: A randomised control trial

Heart

Volumn 102, Issue 17, 2016, Pages 1371-1379

  Noad, Rebecca L ^a,b   Rooney, Ciara ^a   McCall, Damian ^b   Young, Ian S ^a,b   McCance, David ^b   McKinley, Michelle C ^a,c   Woodside, Jayne V ^a,c   McKeown, Pascal P ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; EPICATECHIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYCOPENE; POLYPHENOL; TRIACYLGLYCEROL; XANTHOPHYLL; ZEAXANTHIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BERRY; BODY MASS; CACAO; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY COMPLIANCE; DIETARY INTAKE; FEMALE; FOREARM BLOOD FLOW; FRUIT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; VEGETABLE; VEIN OCCLUSION PLETHYSMOGRAPHY; AGED; BLOOD; CHOCOLATE; DIET THERAPY; DIETARY REFERENCE INTAKE; HEALTHY DIET; MEDITERRANEAN DIET; MICROCIRCULATION; MICROVASCULATURE; MIDDLE AGED; NORTHERN IRELAND; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; TIME FACTOR; TREATMENT OUTCOME; VASODILATATION;

ADULT; AGED; BIOMARKERS; CHOCOLATE; DIET, MEDITERRANEAN; FEMALE; FRUIT; HEALTHY DIET; HUMANS; HYPERTENSION; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; NORTHERN IRELAND; PATIENT COMPLIANCE; POLYPHENOLS; RECOMMENDED DIETARY ALLOWANCES; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME; VASODILATION; VEGETABLES;

EID: 84973375991     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-309218     Document Type: Article

References (30)

1. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-24.
2. McCall DO, McGartland CP, McKinley MC, et al. Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. Circulation 2009; 119: 2153-60.
3. Cassidy A, Mukamal KJ, Liu L, et al. High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 2013; 127: 188-96.
4. McCullough ML, Peterson JJ, Patel R, et al. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 2012; 95: 454-64.
5. Buijsse B, Feskens EJ, Kok FJ, et al. Cocoa intake, blood pressure and cardiovascular mortality. The Zutphen Elderly Study. Arch Intern Med 2006; 166: 411-17.
6. Buijsse B, Weikert C, Drogan D, et al. Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults. Eur Heart J 2010; 31: 1616-23.
7. Janszky I, Mukamal KJ, Ljung R, et al. Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med 2009; 266: 248-57.
8. Panza JA, Quyyumi AA, Brush JE, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7.
9. Linder L, Kiowski W, Buhler FR, et al. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation 1990; 81: 1762-7.
10. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-6.
11. Fichtlscherer S, Breuer S, Zeiher AM. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient. Circulation 2004; 110: 1926-32.
12. Taddei S, Virdis A, Mattei P, et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91: 1981-7.
13. ESH/ESC. 2013 ESH/ESC guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2013: 34: 2159-219.
14. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC Guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129(Suppl 2): S76-99.
15. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management (BHS-IV): summary. BMJ 2004; 328: 634-40.
16. Kroke A, Klipstein-Grobusch K, Voss S, et al. Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. Am J Clin Nutr 1999; 70: 439-47.
17. Spencer JP, Abd El Mohsen MM, Minihane AM, et al. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr 2008; 99: 12-22.
18. Wilkinson IB, Webb DJ. Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol 2001; 38: 1461-6.
19. Vuilleumier JP, Keck E. Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J Micronutrient Anal 1989; 5: 25-34.
20. Craft NE. Carotenoid reversed-phase high-performance liquid chromatography methods: reference compendium. Meth Enzymol 1992; 213: 185-205.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
22. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
23. Gottumukkala RVSS, Nadimpalli N, Sukala K, et al. Determination of Catechin and Epicatechin content in chocolates by high-performance liquid chromatography. Int Scholar Res Notes 2014; 2014: 1-5.
24. Roura E, Almajano MP, Bilbao MLM, et al. Human urine: epicatechin metabolites and antioxidant activity after cocoa beverage intake. Free Radic Res 2007; 41: 943-9.
25. Baba S, Osakabe N, Kato Y, et al. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am J Clin Nutr 2007; 85: 709-17.
26. Rooney C. Polyphenol intake, Dietary Patterns and Psychological Analysis. 2013 Unpublished PhD thesis. Queen's University Belfast.
27. Tu YK, Gilthorpe MS. Revisiting the relation between change and initial value: a review and evaluation. Stat Med 2007; 26: 443-57.
28. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel II Guidelines. J Am Coll Cardiol 2004; 44: 720-32.
29. Nijveldt RJ, van Nood E, van Hoorn DE, et al. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74: 418-25.
30. Andújar I, Recio MC, Giner RM, et al. Cocoa polyphenols and their potential benefits for human health. Oxid Med Cell Longev 2012; 2012: 1-23.